Evaluation of Serum Biochemical Parameters, Visfatin, and C-Reactive Protein Concentrations in Obese Versus Non-Obese Cats

PDF
Published: Feb 11, 2026
DOI: https://doi.org/10.12681/jhvms.41012
Keywords:
adipokine biomarker body condition scoring cat pbesity
M Çıkma
1Harran University, Veterinary Faculty, Department of Internal Medicine, Şanlıurfa, Türkiye
E Gülersoy
1Harran University, Veterinary Faculty, Department of Internal Medicine, Şanlıurfa, Türkiye
Abstract

Obesity in cats is associated with chronic low-grade systemic inflammation, driven by an acute-phase response from adipose tissue. In addition to increasing disease risk, obesity also reduces lifespan. This study aimed, for the first time, to evaluate visfatin levels in clinically healthy-appearing obese cats, assess their relationship with C-reactive protein (CRP) and selected biochemical parameters, and explore their utility as early biomarkers of obesity-related changes. A total of 194 cats presented for routine health checks and vaccinations were screened; after applying inclusion and exclusion criteria, 40 were assigned to the Obese group and 20 to the Control group. All cats underwent physical examination, complete blood count (CBC), serum biochemistry analysis, and measurements of serum CRP and visfatin levels. Body condition score and body weight were significantly higher in the Obese group (p<0.000). While CBC values remained within reference ranges, monocyte (p<0.027) and RDW (p<0.000) levels were significantly elevated in obese cats. Although serum biochemistry values were within reference ranges, the Obese group had significantly higher BUN (p<0.012) and total bilirubin (p<0.000), and lower ALT levels (p<0.035). Serum CRP (p<0.000) and visfatin (p<0.001) levels were also markedly elevated in obese cats. Diagnostic evaluation indicated that monocyte count, AST, LDH, and GGT had acceptable value, RDW, BUN, and visfatin had excellent value, and CRP and total bilirubin demonstrated outstanding diagnostic utility for identifying subclinical inflammation. In conclusion, the findings highlight the persistence of chronic low-grade inflammation in obese cats, even in the absence of clinical signs. Routine monitoring of CRP and visfatin, along with dietary and behavioral interventions, may be crucial for early detection and management of obesity and its related comorbidities in at-risk cats.

Article Details
  • Section
  • Research Articles
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Authors who publish with this journal agree to the following terms:

· Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution Non-Commercial License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

· Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g. post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.

· Authors are permitted and encouraged to post their work online (preferably in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.

Downloads
Download data is not yet available.
References
Aguiar DS, Torres MAO, Chaves DP (2018) Biochemical serum profile
of obese domestic cats from São Luís city, Maranhão. Rev Cienc
Agroveter 17:254–259.
Allan F, Pfeiffer D, Jones B, Esslemont D, Wiseman M (2000) A
cross-sectional study of risk factors for obesity in cats in New
Zealand. Prev Vet Med 46:183–196.
Bauer JE (1996) Comparative lipid and lipoprotein metabolism. Vet
Clin Pathol 25:49–56.
Biourge VC, Massat B, Groff JM, Morris JG, Rogers QR (1994) Effects
of protein, lipid, or carbohydrate supplementation on hepatic lipid
accumulation during rapid weight loss in obese cats. Am J Vet Res
:1406-1415.
Burkholder WJ (2000) Use of body condition scores in the clinical
assessment of the provision of optimal nutrition. J Am Vet Med
Assoc 217:650–654.
Chang YH, Chang DM, Lin KC, Shin SJ, Lee YJ (2011) Visfatin in
overweight/obesity, type 2 diabetes mellitus, insulin resistance,
metabolic syndrome, and cardiovascular diseases: a meta-analysis
and systemic review. Diabetes Metab Res Rev 27:515–527.
Coppack SW (2001) Pro-inflammatory cytokines and adipose tissue.
Proc Nurt Soc 60:349–356.
Corbee RJ (2014) Obesity in show cats. J Anim Physiol Anim Nutr
:1075–1080.
Courcier EA, Mellor DJ, Pendlebury E, Evans C, Yam PS (2012) An
investigation into the epidemiology of feline obesity in Great Britain:
Results of a cross-sectional study of 47 companion animal
practises. Vet Record 171:560.
De Luis DA, Gonzalez Sagrado M, Conde R, Aller R, Izaola O, Romero
E (2008) Effect of a hypocaloric diet on serum visfatin in overweight
non-diabetic patients. Nutrition 24:517e21.
Fantuzzi G (2005) Adipose tissue, adipokines, and inflammation. J Allergy
Clin Immunol 115:911–919.
Fettman MJ, Stanton CA, Banks LL (1997) Effects of neutering on body
weight, metabolic rate, and glucose intolerance of domestic cats.
Res Vet Sci 62:131-136.
Förhécz Z, Gombos T, Borgulya G, Pozsonyi Z, Prohászka Z, Jánoskuti
L. Red (2009) Cell distribution width in heart failure: prediction of
clinical events and relationship with markers of ineffective erythropoiesis,
inflammation, renal function, and nutritional state. Am
Heart J 158:659–666.
Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto
K (2005) Visfatin: a protein secreted by visceral fat that mimics
the effects of insulin. Science 307:426e30.
Fukuhara A, Matsuda M, Nishizawa M, Segawa K, Tanaka M, Kishimoto
K (2007) Ret Sci 318:565.
German AJ, Holden SL, Moxham G (2006) A simple, reliable tool for
owners to assess the body condition of their dog or cat. J Nutr
:2031S-2033S.
German AJ (2006) The growing problem of obesity in dogs and cats. J
Nutr 136:1940S-1946S.
Gkrinia EMM, Belančić A (2025) The Mechanisms of Chronic Inflammation
in Obesity and Potential Therapeutic Strategies: A Narrative
Review. Curr Issues Mol Biol 47:357.
Gregor MF, Hotamisligil GS (2011) Inflammatory mechanisms in obesity.
Annu Rev Immunol 29:415–445.
Gruys E, Toussaınt M, Landman W (1999) Infection, inflammation and
stress inhibit growth. Mechanisms and non-specific assessment of
the processes by Acute Phase Proteins. In: Production diseases in
farm animals. 10th international Conference, Wageningen: pp 72-87.
Gülersoy E, Erol BB, Ok M, Sevinç M (2023) Evaluation of qSOFA and
variation of hematochemical profile in cats naturally infected with
feline panleukopenia virus. Open Vet Sci 4: 20220118.
Hamper B (2016) Current topics in canine and feline obesity. Vet Clin
N Am 46:785–795.
Harman-Boehm I, Bluher M, Redel H (2007) Macrophage infiltration
into omental versus subcutaneous fat across different populations:
effect of regional adiposity and the comorbidities of obesity. J Clin
Endocrinol Metab 92:2240–2247.
References
Heinrich P, Behrmann I, Müller-Newen G, Schaper F, Graeve L (1998)
Interleukin-6-type cytokine signalling through the gp130/Jak/STAT
pathway. Biochem J 334:297-314.
Hoenig M, Ferguson DC (2002) Effects of neutering on hormonal concentrations
and energy requirements in male and female cats. Am
J Vet Res 63:634-639.
Hoenig M, Wilkins C, Holson JC, Ferguson DC (2003) Effects of obesity
on lipid profiles in neutered male and female cats. Am J Vet
Res 64:299–303.
Huang L, Wang Z, Pan Y, Zhou K, Zhong S (2024) Correlation Between
Blood Urea Nitrogen and Short- and Long-Term Glycemic
Variability in Elderly Patients with Type 2 Diabetes Mellitus Who
Were hospitalized:A Retrospective Study. Diabetes Metab Syndr
Obes 17:1973-1986.
Jeemon P, Prabhakaran D, Huffman MD, Ramakrishnan L, Goenka S,
Thankappan M (2011) Distribution of 10-year and lifetime predicted
risk for cardiovascular disease in the Indian Sentinel Surveillance.
BMJ 1:1.
Laflamme DP (1997) Development and validation of a body condition
score system for cats: a clinical tool. Feline Pract 25:13-18.
Laflamme DP (2006) Understanding and managing obesity. Vet Clin
North Am Small Anim Pract 36:1283-1295.
Lalor S, Gunn-Moore D, Cash R (2014) Serum Cardiac Troponin I
concentrations in cats with anaemia - a preliminary, single-centre
observational study. J Small Anim Pract 55:320–322.
Lund EM (2005) Prevalence and risk factors for obesity in adult cats
from private us veterinary practices. Int J Appl Res Vet Med
:88–96.
Martin L, Siliart B, Dumon H (2001) Leptin, body fat content and energy
expenditure in intact and gonadectomised adult cats: a preliminary
study. J Anim Phys Anim Nutr 85:195-199.
Michel K, Scherk M (2012) From problem to success: Feline weight
loss programs that work. J Felin Med Sur g 14:327–336.
Mori N, Kawasumi K, Suzuki T (2012) Establishment of Temporary
Criteria for Metabolic Syndrome (MS) Diagnosis and Assessment
of the Occurrence Rate of MS in Cats. J Anim Vet Adv 11:615–617.
Morton GJ, Schwartz MW (2011) Leptin and the central nervous system
control of glucose metabolism. Physiol Rev 91:389–411.
Moschen AR, Kaser A, Enrich B, Mosheimer B, Theurl M, Niederegger
H (2007) Visfatin, an adipocytokine with proinflammatory and immunomodulating
properties. J Immunol 178:1748e58.
Nguyen PG, Dumon HJ, Siliart B (2004) Effects of dietary fat and energy
on body weight and composition after gonadectomy in cats. Am J
Vet Res 65:1708-1713.
Pagano C, Pilon C, Olivieri M, Mason P, Fabris R, Serra R (2006) Reduced
plasma visfatin/Pre-B cell colony-enhancing factor in obesity
is not related to insulin resistance in humans. J Clin Endocrinol
Metab 91:3165e70.
Patel KV, Semba RD, Ferrucci L (2010) Red cell distribution width
and mortality in older adults: a meta-analysis. J Gerontol A Biol
Sci Med Sci 65:258–265.
Patterson CM, Levin BE (2008) Role of exercise in the central regulation
of energy homeostasis and in prevention of obesity. Neuroendocrinology
:65-70.
Prahl A, Guptill L, Glickman NW (2007) Time trends and risk factors for
diabetes mellitus in cats presented to veterinary teaching hospitals.
J Feline Med Surg 9:351-358.
Prucha M (2015) Sepsis. Clin Chim Acta 440:97–103.
Radakovich LB, Truelove MP, Pannone SC (2017) Clinically healthy
overweight and obese dogs differ from lean controls in select CBC
and serum biochemistry values. Vet Clin Pathol 46:221–226.
Radin MJ, Sharkey LC, Holycross BJ (2009) Adipokines: A review of
biological and analytical principles and an update in dogs, cats,
and horses. Vet Clin Pathol 38:136–156.
Saely CH, Vonbank A, Rein P (2008) Alanine aminotransferase and gamma-
glutamyl transferase are associated with the metabolic syndrome
but not with angiographically determined coronary atherosclerosis.
Clin Chim Acta 397:82–86.
Samal B, Sun Y, Stearns G, Xie C, Suggs S, McNiece I (1994) Cloning
and characterization of the cDNA encoding a novel human pre-Bcell
colony-enhancing factor. Mol Cell Biol 14:1431e7.
Shilpa BA, Jayashree SB, Amruta M, Mangesh T, Balaji NA (2014) High
sensitivity C-reactive protein : An independent proinflammatory
cardiac marker in Healthy Overweight and Obese individuals. J
Res Obes 17:1-8.
Teng KT, McGreevy PD, Toribio JL (2018) Raubenheimer D, Kendall K,
Dhand NK. Strong associations of nine-point body condition scoring
with survival and lifespan in cats. J Feline Med Surg 20:1110-1118.
Van Gaal LF, Mertens IL, De Block CE (2006) Mechanisms linking
obesity with cardiovascular disease. Nature 444:875-880.
Verschuur M, Bekkers M, Van Erck MG, Emeıs JJ, De Maat MP (2001)
Influence of plasma triglyceride and plasma cholesterol levels on
the clearance rate of fibrinogen. Ann NY Acad Sci 936:639-642.
Wang Z, Nakayama T (2010) Inflammation, a link between obesity and
cardiovascular disease. Mediators Inflam 535:1-17.
Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante
AW Jr (2003) Obesity is associated with macrophage accumulation
in adipose tissue. J Clin Invest 112:1796–1808.
World Health Organization (2021) Obesity : Preventing and Managing
the Global Epidemic : Report of a WHO Consultation. World Health
Organization 1-12.
Wisse BE (2004) The inflammatory syndrome: the role of adipose tis -
sue cytokines in metabolic disorders linked to obesity. J Am Soc
Nephrol 15:2792-2800.
Yin C, Hu W, Wang M, Xiao Y (2019) The role of the adipocytokines
vaspin and visfatin in vascular endothelial function and insulin
resistance in obese children. BMC Endocr Disord 19:127.
Most read articles by the same author(s)